Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on May 14, 2014. The filing covers corporate governance events and shareholder voting results from the Annual Meeting of Shareholders held on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder actions rather than financial performance.
Material Changes and Corporate Actions
Executive Appointment
On May 14, 2014, the Board of Directors appointed Joseph R. Swedish to the position of President, in addition to his existing role as Chief Executive Officer, effective immediately.
Shareholder Voting Results
- Election of Directors: All four nominees (R. Kerry Clark, Robert L. Dixon, Jr., Lewis Hay, III, and William J. Ryan) were elected to three-year terms expiring in 2017. Each received over 215 million votes in favor.
- Independent Auditor: The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2014 was ratified with 230,614,202 votes in favor.
- Executive Compensation: The advisory vote on executive compensation was approved with 204,906,522 votes in favor, though 13,222,491 votes were cast against.
- Shareholder Proposal: A proposal to amend By-Laws to prohibit political contributions was not approved. It received 3,428,933 votes in favor and 204,513,515 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document references the 2014 Proxy Statement for additional information regarding Mr. Swedish.
Investor Verification Checklist
- Verify the dual role of Joseph R. Swedish as both CEO and President.
- Confirm the re-election of the four board members for terms ending in 2017.
- Note the significant opposition (approx. 6.4%) to the executive compensation advisory vote.
- Review the 2014 Proxy Statement for detailed biographical information on the newly appointed President.